Xiaosuo Wang | Technological Networks | Best Researcher Award

Published on by Network Science

Dr. Xiaosuo Wang | Technological Networks | Best Researcher Award

The University of Sydney | Australia

Dr. Xiaosuo Wang is a distinguished researcher specializing in mass spectrometry, metabolomics, lipidomics, and proteomics, with deep expertise in vascular biology and heart failure. She earned her PhD in Medicine from the University of Sydney in 2009, focusing on novel ELISA methods to detect oxidised apolipoproteins in cardiovascular disease, following a master’s degree in Physiology and Pharmacology from the University of New South Wales and a bachelor’s in Biomedical Engineering from the Fourth Military Medical University, China. Currently a Senior Research Fellow and Senior Lecturer at the University of Sydney’s Charles Perkins Centre, she leads pioneering projects in biomarker discovery, metabolic assays, and multi-omics platform development for applications in liver disease, heart failure, and population health. Her work integrates advanced mass spectrometry, lipidomics, and metabolomics workflows with translational innovations such as point-of-care assays and biosensor development. Previously, as a Metabolomics Research Scientist at the Victor Chang Cardiac Research Institute and Manager of the Bosch Mass Spectrometry Facility, she developed over 60 advanced LC-MS assays and supported a wide range of biological and clinical research. Dr. Wang’s prolific contributions include more than 40 peer-reviewed publications, numerous conference presentations, and significant advancements in analytical methodologies for precision medicine.

Profiles: Scopus | Orcid ID

Featured Publications

"Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass Spectrometry. Pharmaceuticals, Xiaosuo Wang; Wei Yi Lew; Yang Yang; Nan Zhang; Jiexun Bu; Zhentao Li; Michael Fitzpatrick; Paul Bonnitcha; David Sullivan; Wenpeng Zhang et al., 2025"

"The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD + Therapy in HFpEF, Circulation Research, Yen Chin Koay; Bailey McIntosh; Yann Huey Ng; Yang Cao; Xiao Suo Wang; Yanchuang Han; Saki Tomita; Angela Yu Bai; Benjamin Hunter; Ashish Misra et al., 2025"

"Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEF, JACC. Basic to translational science, O'Sullivan JF; Li M; Koay YC; Wang XS; Guglielmi G; Marques FZ; Nanayakkara S; Mariani J; Slaughter E; Kaye DM, 2024"

"The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease, Pathology, Qadri S; Wang X; Tran C; Fitzpatrick M; Bonnitcha P; Sullivan D; Yki-Järvinen H; O'Sullivan JF, 2023"

"Destabilization of Atherosclerotic Plaque by Bilirubin Deficiency, Circulation Research, Weiyu Chen; Sergey Tumanov; Christopher P. Stanley; Stephanie M.Y. Kong; James Nadel; Niv Vigder; Darren L. Newington; Xiao Suo Wang; Louise L. Dunn; Roland Stocker, 2025"

Anna Maria Pittaluga | Biological Networks | Top Researcher Award

Published on by Network Science

Prof. Anna Maria Pittaluga | Biological Networks | Top Researcher Award

University of Genoa | Italy

Anna Maria Pittaluga is a distinguished pharmacologist with a PhD in Pharmacology and Toxicology from the University of Turin (1990), and MSc degrees in Pharmacy (1983) and in Pharmaceutical Chemistry and Technology with honors (1982) from the University of Genova. She has built a long-standing academic career at the University of Genoa, where she has served as Assistant Professor (1993–2003), Associate Professor (2004–2019), and currently as Full Professor of Pharmacology since 2019. Earlier in her career, she gained international research experience as a Research Fellow at the Italian National Research Council (1990–1992) and as a Foreign Research Associate at Collège de France in Paris (1988–1989). Her scientific interests focus on neurotransmitter release mechanisms, receptor interactions, the effects of HIV-1 proteins and chemokines on central neurotransmission, synaptic function in multiple sclerosis, the neuro-immune interface, and the role of nutraceutics in brain health. She has led numerous national and international projects funded by the Italian Ministry of Research, Ministry of Health, and European programs, serving as principal investigator on studies addressing neuroinflammation, depression, synaptopathies, and the gut-brain axis. Proficient in English and French, in addition to her native Italian, Professor Pittaluga has made significant contributions to advancing pharmacological research with strong translational and clinical implications.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Correction: Vallarino et al. Healthy Properties of a New Formulation of Pomegranate-Peel Extract in Mice Suffering from Experimental Autoimmune Encephalomyelitis"

"Unveiling Niaprazine’s Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent"

"Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis"

"Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic"

"Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720"